Hamza, Suzan A., Namir I. A. Haddad, and Gheyath AL Gawwam. “The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study”. INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES (February 10, 2026): 335–345. Accessed October 23, 2026. https://xlescience.org/index.php/IJASIS/article/view/785.